Company Contact:
Chiral Technologies Inc.
610-594-2100
levangelista@chiraltech.com

Company E-mail:
chiral@chiraltech.com
<< Back
2/25/07
FOR IMMEDIATE RELEASE
 
Chiral Technologies, Inc., Announces the Third Addition to Its New Generation of Immobilized Technology Analytical Column Product Line—CHIRALPAKŪ IC

Chicago, IL– February 25, 2007– CHIRAL TECHNOLOGIES, INC., a wholly owned subsidiary of Daicel Chemical Industries, Ltd., of Japan, announced today, at the Pittsburgh Conference 2007 in Chicago, the newest addition to their polysaccharide product lineup, CHIRALPAK® IC HPLC columns.

CHIRALPAK IC is the third in a new series of robust columns that has been prepared using a Daicel immobilization technology on a novel CSP (Chiral Stationary Phase) that exhibits remarkable stability, separation reproducibility and column durability when used in normal phase, reverse phase and SFC modes.

In screening, when combined with the CHIRALPAK IA and CHIRALPAK IB, the CHIRALPAK IC will result in new and robust separations with exceptionally high success rates, using fewer columns and a limited number of mobile phases.

In preparative separations the addition of IC to the immobilized Daicel range increases the potential to find a highly productive separation that matches the column selectivity to the solvent that best suits the racemate.

In method development, due to the novel nature of the CSP, the column can undertake new, improved and complementary separations using both normal and extended mobile phases.

At launch the column will be available in analytical size columns (250 x 4.6 and 150 x 4.6). Semi preparative, SFC and microbore columns as well as bulk CSP(20 µm particle size) will be available shortly after.

In addition to chiral chromatography columns, CHIRAL TECHNOLOGIES, INC., also supplies bulk chiral stationary phases and preparative chiral columns for chromatographic resolution of single enantiomer compounds. At its technical center in
West Chester, PA (suburb of Philadelphia), the company operates an Outsourcing Center for Separation of chiral intermediates and APIs in pre-clinical and clinical evaluation. This facility utilizes state-of-the-art chromatography equipment—
SMB (also known as multi-column chromatography [MCC]), supercritical fluid chromatography (SFC), and traditional single column preparative HPLC systems.

CHIRAL TECHNOLOGIES, INC., was established in 1990, and has served the pharmaceutical and other life science industries during this period of rapid growth of chiral pharmaceuticals.

Additional information can be obtained by contacting CHIRAL TECHNOLOGIES, INC., as follows:

CHIRAL TECHNOLOGIES, INC.
800 North Five Points Road
West Chester, PA 19380
Telephone: 610-594-2100
Fax: 610-594-2325w.safedata.net.

Back to Top